Edition:
United Kingdom

Tibet Rhodiola Pharmaceutical Holding Co (600211.SS)

600211.SS on Shanghai Stock Exchange

37.73CNY
3:25am GMT
Change (% chg)

¥1.91 (+5.33%)
Prev Close
¥35.82
Open
¥36.00
Day's High
¥37.80
Day's Low
¥36.00
Volume
1,017,516
Avg. Vol
990,631
52-wk High
¥56.98
52-wk Low
¥35.02

Latest Key Developments (Source: Significant Developments)

Tibet Rhodiola Pharmaceutical Holding says unfrozen of 11.13 pct stake
Tuesday, 21 Nov 2017 

Nov 21(Reuters) - Tibet Rhodiola Pharmaceutical Holding Co <600211.SS>:Says 11.13 percent stake held by co's shareholder was unfrozen on Nov. 17.  Full Article

Tibet Rhodiola Pharmaceutical Holding says unfrozen of 17.53 pct stake
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Tibet Rhodiola Pharmaceutical Holding Co Ltd <600211.SS> ::Says 17.53 percent stake(31.5 million shares) held by shareholder was unfrozen on Oct. 31 .  Full Article

Tibet Rhodiola Pharmaceutical Holding announces change in accounting policy
Thursday, 17 Aug 2017 

Aug 17(Reuters) - Tibet Rhodiola Pharmaceutical Holding Co <600211.SS>:Says it changes accounting policy based on accounting standards for business enterprises.  Full Article

Tibet Rhodiola Pharmaceutical to appoint Ruihua Certified Public Accountants as 2016 cooperate auditor
Monday, 8 Aug 2016 

Tibet Rhodiola Pharmaceutical Co., Ltd. <600211.SS>:Says it will appoint Ruihua Certified Public Accountants as 2016 cooperate auditor, to replace Sichuan Huaxin(Group) CPA Firm.  Full Article

Tibet Rhodiola Pharmaceutical Holding merges 100-pct-owned Tibet pharmaceutical unit
Monday, 11 Jul 2016 

Tibet Rhodiola Pharmaceutical Holding Co <600211.SS>:Says it completed merger with a wholly owned unit, a Tibet-based pharmaceutical unit.  Full Article

Tibet Rhodiola Pharmaceutical to pay 2015 dividend on June 2
Friday, 27 May 2016 

Tibet Rhodiola Pharmaceutical Co Ltd <600211.SS> : Says it plans to pay a cash dividend of 0.19 yuan (before tax) per 10 shares to shareholders of record on June 1, for 2015 .Says the company's shares will be traded ex-right and ex-dividend on June 2 and the dividend will be paid on June 2.  Full Article

Tibet Rhodiola Pharmaceutical appoints Zhou Xiaobin as CFO
Tuesday, 10 May 2016 

Tibet Rhodiola Pharmaceutical Co., Ltd. <600211.SS> :Says it appoints Zhou Xiaobin as CFO of the company, to replace Cao Shuzhen, who has resigned from the position.  Full Article

Tibet Rhodiola Pharmaceutical Holding announces 2015 dividend payment
Saturday, 19 Mar 2016 

Tibet Rhodiola Pharmaceutical Holding Co:To use undistributed profits to pay cash dividend of 1.9 yuan per 10 shares (before tax) to shareholders for 2015.  Full Article

Tibet Rhodiola Pharmaceutical Holding subsidiary signs asset purchase agreement
Tuesday, 1 Mar 2016 

Tibet Rhodiola Pharmaceutical Holding Co:Wholly owned subsidiary Everest Future Limited, China Medical System Holdings Ltd and Everest Fortune Limited sign asset purchase agreement with ASTRAZENECA AB on Feb. 26.Everest Future will buy IMDUR product and brand related assets, which are including IMDUR, MONODUR and DURONTITRIN from ASTRAZENECA AB, for $190 mln.  Full Article

Tibet Rhodiola Pharmaceutical Holding to issue new shares through private placement
Tuesday, 1 Mar 2016 

Tibet Rhodiola Pharmaceutical Holding Co:To issue up to 42.6 million A shares of its common stock through private placement to six parties, at 35.21 yuan per share.To raise up to 1.5 billion yuan in total.Proceeds raised will be used for IMDUR acquisition and working capital supplement.  Full Article